Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.

Original publication




Journal article


Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Publication Date





The European Centre for Disease Prevention and Control, Stockholm, Sweden.


WHO European Region sequencing laboratories and GISAID EpiCoV group, WHO European Region sequencing laboratories and GISAID EpiCoV group*, Humans, Coronavirus, Pneumonia, Viral, Coronavirus Infections, Severe Acute Respiratory Syndrome, RNA, Viral, Base Sequence, Genome, Viral, World Health Organization, Europe, Pandemics, Phylogeography, Spatio-Temporal Analysis, Betacoronavirus, RNA-Dependent RNA Polymerase, COVID-19, SARS-CoV-2